Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion

Redman, JM; Rhea, LP; Brofferio, A; Whelpley, M; Gulley, JL; Gatti-Mays, ME; McMahon, S; Cordes, LM; Strauss, J

Redman, JM (reprint author), NCI, Genitourinary Malignancy Branch, Lab Tumor Immunol & Biol, NIH, 10 Ctr Dr,Room 13N240, Bethesda, MD 20892 USA.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019; 10 (5): 1010

Abstract

5-fluorouracil (5-FU) is an important component of chemotherapy for metastatic colon cancer and can be administered as an intravenous infusion or bolu......

Full Text Link